mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |